We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Linagliptin

Linagliptin | CAS NO: 668270-12-0 Linagliptin is primarily used for the management of type 2 diabetes mellitus. Blood Sugar Control: Linagliptin helps lower blood glucose levels by increasing insulin secretion and decreasing glucagon levels in response to meals. Combination Therapy: Linagliptin can be combined with other diabetes medications, such as metformin or insulin, to improve glycemic control. Always consult a healthcare professional for personalized medical advice and treatment options.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Linagliptin impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities It can be used alone when diet and exercise are not enough to control blood sugar.Type 2 Diabetes Management: To improve blood sugar control in adults with type 2 diabetes. Monotherapy: As a standalone treatment when diet and exercise alone are insufficient. Combination Therapy: Used alongside other diabetes medications (like metformin or insulin) to enhance glycemic control. we the Synchemia are ensuring the purity and quality of its impurities which is crucial for pharmaceutical API manufacturing companies for regulatory compliance. Buy Reliable and High-Purity Linagliptin Impurities, Delivered by Synchemia Research Chemicals.

download image Download catalogue

Pharmaceutical Reference Standards

Linagliptin EP Impurity L
Linagliptin EP Impurity L
CAT No SRC-L12048
CAS No 2416949-69-2
Mol.F. C25H29N7O4
Mol.Wt. 491.6g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin EP Impurity F
Linagliptin EP Impurity F
CAT No SRC-L12049
CAS No NA
Mol.F. C52H58N16O4
Mol.Wt. 971.1g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin 2-Chloromethyl Impurity
Linagliptin 2-Chloromethyl Impurity
CAT No SRC-L12050
CAS No 109113-72-6
Mol.F. C10H9ClN2
Mol.Wt. 192.7g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin 8-Bromo Impurity
Linagliptin 8-Bromo Impurity
CAT No SRC-L12861
CAS No 93703-24-3
Mol.F. C6H5BrN4O2
Mol.Wt. 245g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Stereochemical Impurity
Linagliptin Stereochemical Impurity
CAT No SRC-L12862
CAS No 1383917-84-7
Mol.F. C25H28N8O2
Mol.Wt. 472.6g/mole
INV STATUS CUSTOM SYNTHESIS
N-Carbamoyl Linagliptin
N-Carbamoyl Linagliptin
CAT No SRC-L12863
CAS No 2983074-55-9
Mol.F. C26H29N9O3
Mol.Wt. 515.6 g/mole
INV STATUS UNDER SYNTHESIS
N-Depiperidin-3-Amine Linagliptin Dimer
N-Depiperidin-3-Amine Linagliptin Dimer
CAT No SRC-L12864
CAS No 2253964-98-4
Mol.F. C45H44N14O4
Mol.Wt. 844.9g/mole
INV STATUS IN STOCK
Linagliptin Impurity-VII
Linagliptin Impurity-VII
CAT No SRC-L12865
CAS No NA
Mol.F. C31H38N8O7
Mol.Wt. 634.7g/mole
INV STATUS CUSTOM SYNTHESIS
2-(Chloro methyl)quinazoline
2-(Chloro methyl)quinazoline
CAT No SRC-L12866
CAS No 6148-18-1
Mol.F. C9H7ClN2
Mol.Wt. 178.6g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Dimer Impurity
Linagliptin Dimer Impurity
CAT No SRC-L12867
CAS No NA
Mol.F. C52H59N17O4
Mol.Wt. 986.2g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Dimer Impurity 3
Linagliptin Dimer Impurity 3
CAT No SRC-L12868
CAS No NA
Mol.F. C52H60N16O4
Mol.Wt. 973.2g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Dimer Impurity 5
Linagliptin Dimer Impurity 5
CAT No SRC-L12869
CAS No NA
Mol.F. C60H62N18O4
Mol.Wt. 1099.3g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Dimer Impurity 7
Linagliptin Dimer Impurity 7
CAT No SRC-L12870
CAS No NA
Mol.F. C57H60N16O4
Mol.Wt. 1033.2g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Dimer Impurity 8
Linagliptin Dimer Impurity 8
CAT No SRC-L12871
CAS No NA
Mol.F. C51H56N16O4
Mol.Wt. 957.1g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Dimer Impurity 9
Linagliptin Dimer Impurity 9
CAT No SRC-L12872
CAS No NA
Mol.F. C51H56N16O4
Mol.Wt. 957.1g/mole
INV STATUS CUSTOM SYNTHESIS
Linagliptin Fumaric Acid Adduct Na Salt
Linagliptin Fumaric Acid Adduct Na Salt
CAT No SRC-L12873
CAS No NA
Mol.F. C29H30N8O6 : 2(Na)
Mol.Wt. 586.6 : 2(23.0)g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.